Korean Treatment Guidelines for Metastatic Prostate Cancer Developed by the Korean Association for Clinical Oncology / 대한내과학회지
Korean Journal of Medicine
; : 124-141, 2017.
Article
em Ko
| WPRIM
| ID: wpr-193491
Biblioteca responsável:
WPRO
ABSTRACT
The management of advanced prostate cancer has evolved rapidly. Androgen deprivation therapy, via surgical or medical castration, is the first-line therapy for hormone-naïve metastatic prostate cancer. For approximately a decade, docetaxel-based chemotherapy was the only approved agent to show a survival benefit for castration-resistant prostate cancer. However, over the last 5 years, significant advances in the field have led to the approval of several new agents with different mechanisms of action, such as the new androgen pathway inhibitors abiraterone and enzalutamide, a new cytotoxic agent, cabazitaxel, and new bone-seeking agents such as radium-223, which have all been associated with improved quality of life and pain palliation and an increase in survival. However, there has been no Korean treatment guideline for metastatic prostate cancer which is developed based on thorough search for relevant articles, including recently developed agents, and adequate review and assessment of evidences, and thus, a guideline adequate for domestic circumstance is eagerly needed. Experts from the Genitourinary Oncology Committee of the Korea Cancer Study Group developed clinical recommendations for the treatment of metastatic prostate cancer based on 19 key questions. The Korean Association for Clinical Oncology, the Korean Prostate Society, the Korean Urological Oncology Society, and the Korean Society of Pathologists reviewed and endorsed the guidelines. These are the first Korean treatment guidelines developed specifically for metastatic prostate cancer.
Palavras-chave
Texto completo:
1
Base de dados:
WPRIM
Assunto principal:
Próstata
/
Neoplasias da Próstata
/
Qualidade de Vida
/
Castração
/
Tratamento Farmacológico
/
Coreia (Geográfico)
/
Oncologia
/
Metástase Neoplásica
Tipo de estudo:
Guideline
Aspecto:
Patient_preference
País/Região como assunto:
Asia
Idioma:
Ko
Revista:
Korean Journal of Medicine
Ano de publicação:
2017
Tipo de documento:
Article